Fidencio Cons-Molina

Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial

Désirée van der Heijde, James Cheng‐Chung Wei, Maxime Dougados et al. · The Lancet · 2018 · 349 citations · Full text

Inflammation, Rheumatology, Rheumatoid Disorder +14

The prevalence of radiographic vertebral fractures in Latin American countries: the Latin American Vertebral Osteoporosis Study (LAVOS)

Patricia Clark, Fidencio Cons-Molina, Margarita Delezé et al. · Osteoporosis International · 2008 · 186 citations

Bone Disease, Bone Health, Radiographic Vertebral Fractures +8

Geographic Differences in Bone Mineral Density of Mexican Women

Margarita Delezé, Fidencio Cons-Molina, Antonio Villa et al. · Osteoporosis International · 2000 · 55 citations

Bone Health, Body Composition, Osteoporosis +5

Association between bone turnover markers, clinical variables, spinal syndesmophytes and bone mineral density in Mexican patients with ankylosing spondylitis

JI Gámez-Nava, LF De la Cerda-Trujillo, María Luisa Vazquez-Villegas et al. · Scandinavian Journal of Rheumatology · 2016 · 23 citations

The prevalence of radiographic vertebral fractures in Mexican men

Patricia Clark, Fidencio Cons-Molina, Margarita Delezé et al. · Osteoporosis International · 2009 · 16 citations · Full text